Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Oligodendroglioma 3Gliosarcoma 3Glioma 3Glioblastoma 3Ependymoma 3Breast Neoplasms 3Astrocytoma 3Pinealoma 2Neuroectodermal Tumors, Primitive 2Meningioma 2Medulloblastoma 2Choroid Plexus Neoplasms 2Brain Neoplasms 2Precancerous Conditions 1Neurofibromatosis 1 1Neurofibroma, Plexiform 1Neoplasms 1Multiple Sclerosis 1Lymphoma, Follicular 1Lung Neoplasms 1Kidney Neoplasms 1Inflammatory Breast Neoplasms 1Glioma, Subependymal 1Craniopharyngioma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Interventions

Magnetic Resonance Spectroscopy 6Temozolomide 4Radiotherapy 4Biopsy 3sargramostim 2Imatinib Mesylate 2Donepezil 2Carboplatin 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2temsirolimus 1gallium Ga 68 dotatate 1fluorodopa F 18 1aldesleukin 1Vinblastine 1Topotecan 1Thalidomide 1Tamoxifen 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Reverse Transcriptase Polymerase Chain Reaction 1Radiation 1Photochemotherapy 1Pharmacogenomic Testing 1O(6)-benzylguanine 1Muromonab-CD3 1Modafinil 1Methylphenidate 1Mental Status and Dementia Tests 1Lapatinib 1Introns 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Glioma, Subependymal × Gadolinium DTPA × Clear all
NCT00005790 2012-06-11

Perfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain Tumors

Northwestern University

Phase NA Withdrawn
CNSSarcoma

Astrocytoma, Craniopharyngioma, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Oligodendroglioma, Pinealoma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡